Less Ads, More Data, More Tools Register for FREE

Cyprotex First-Half Performance Significantly Outpaces Expectations

Wed, 20th Jul 2016 11:48

LONDON (Alliance News) - Contract research organisation Cyprotex PLC on Wednesday said its financial performance in the first half outpaced its expectations and said its strategic review continues.

Cyprotex said its results for the half to the end of 2016 were significantly ahead of its expectations and marked a big improvement on the comparable period a year earlier.

Cyprotex said it is continuing its strategic review, which will consider all options for the company including a sale or the pursuit of strategic partnerships.

The company will publish interim results on August 2.

Shares in Cyprotex were up 10% to 131.00 pence after the news.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.


Shares in this article

Related News

High Court rules that Evotec can buy Cyprotex
13 Dec 2016

High Court rules that Evotec can buy Cyprotex

(ShareCast News) - The High Court on Tuesday sanctioned the scheme of arrangement for German drug discovery company Evotec to buy AIM-listed bioscienc...

Investment boosts revenue and profits at Cyprotex
2 Aug 2016

Investment boosts revenue and profits at Cyprotex

(ShareCast News) - Contract research organisation Cyprotex posted its interim results for the half year to 30 June on Tuesday, with revenues up 26% to...